Diazid 80 mg (Tablet)

Unit Price: ৳ 7.00 (5 x 10: ৳ 350.00)
Strip Price: ৳ 70.00

Medicine Details

Category Details
Generic Gliclazide
Company Nipro jmi pharma ltd

Title and Categories

  • Diazid 80 mg Tablet
  • Oral Antidiabetic Medicine
  • Sulphonylurea Group
  • Type 2 Diabetes Mellitus Treatment

Dimensions

  • Film-coated Tablet
  • Modified Release Preparation
  • Tablet Size: Standard
  • Tablet Size: Modified Release

Color Options

  • Film-coated Tablet: White
  • Modified Release Preparation: White

Functions

  • Reduces Blood Sugar Levels
  • Stimulates Insulin Release
  • Improves Body's Insulin Utilization
  • Supports Managing Type 2 Diabetes
  • Supports Pancreas Function
  • Supports Blood Sugar Control
  • Potentially Useful Hematological Properties

Materials

  • Active Ingredient: Gliclazide
  • Inactive Ingredients: Film-coating Materials
  • Inactive Ingredients: Modified Release Components

Technical Specifications

  • Usual Initial Dose: 40 to 80 mg daily
  • Maximum Dose: 320 mg daily
  • Administration: Before Meal
  • Recommended Daily Dose: 1 to 4 tablets
  • Maximum Daily Dose of Modified Release Preparation: 120 mg
  • Administration Time: Breakfast Time
  • Administration Method: Oral Intake with Water
  • Administration: Whole Tablet Swallowing
  • Administration: Not to be Chewed or Crushed
  • Combination Therapy Dosing: Individualized by Doctor

Design Elements

  • Film-Coated for Easy Swallowing
  • Modified Release for Prolonged Effect
  • Portability: Easy to Carry
  • Clear Dosage Instructions
  • Child-Proof Packaging

Usability Features

  • Dosing Flexibility
  • Instructions for Missed Dose
  • Instructions for Overdose
  • Pregnancy and Breastfeeding Warnings
  • Precautions for Driving and Machine Use
  • Storage Instructions for Safety
  • Disposal Instructions for Environmental Protection
  • Common Questions and General Instructions

Chemical Structure

  • Molecular Formula: C15H21N3O3S
  • Chemical Structure Visualization

Side Effects

  • Low Blood Sugar (Hypoglycaemia)
  • Liver Disorders
  • Skin Disorders
  • Blood Disorders
  • Digestive Disorders
  • Eye Disorders
  • Other Sulfonylurea Adverse Events
  • Reporting of Side Effects

Interaction

  • Medicine Interactions
  • Food and Drink Interactions
  • Impact on Driving and Machine Use
  • Consultation Before Starting Other Medicine
  • Reminder to Inform Medical Staff During Hospitalization
  • Reminder for Alcohol Avoidance

Dosage and Administration

  • Initiation Guidance for Children
  • Individualized Dose Determination
  • Guidance for Combination Therapy Initiation
  • Guidance for Missed Dose
  • Guidance for Stopping the Medicine
  • Guidance for Overdose
  • Guidance for Food and Drink Intake
  • Reminder for Always Eating a Meal after Intake

Indications

  • Type 2 Diabetes Mellitus Treatment
  • Usage When Diet, Exercise, and Weight Loss Alone are Ineffective

Contraindications

  • Allergy to Gliclazide or Related Medicines
  • Insulin-Dependent Diabetes (Type 1)
  • Diabetic Ketoacidosis
  • Severe Kidney or Liver Disease
  • Breastfeeding

Pregnancy & Lactation

  • Not Recommended During Pregnancy
  • Not Recommended During Breastfeeding
  • Consultation Before Use During Pregnancy or Planning for Pregnancy

Precautions & Warnings

  • Regimen Adherence Importance
  • Blood and Urine Sugar Level Monitoring
  • Risk of Reduced Blood Sugar Levels Increase in First Few Weeks
  • Low Blood Sugar (Hypoglycaemia) Symptoms and Management
  • High Blood Sugar (Hyperglycaemia) Symptoms
  • G6PD Deficiency Risk Reminder
  • Not Recommended for Use in Children

Therapeutic Class

  • Sulfonylureas

Storage Conditions

  • Keep Out of Reach and Sight of Children
  • Expiry Date Reminder
  • Temperature Limit for Storage
  • Recommendation for Disposal

Related Brands